Stock Report

All about this stock under one free report Last Updated: 04-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Zealand Pharma A/S - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$17.59

$0.00 (0.00%)

As on 02-Nov-2022 09:30EDT

Market cap

info icon

$814 Mln

Revenue (TTM)

info icon

$176 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

9.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -30.37 74.48 -10.67
EBIT -6.05 17.55 16.03 -218.41 -260.36
Net Profit -- -- -20.24 -220.54 -235.78
EPS -- -- -6.26 -208.09 --
Book Value -- -- -30.34 -15.69 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-21Dec-20
EBIT-Margin info -657.96-94.70-549.20-349.61-236.83
Net Margin info -1,382.77-15.65-400.00----
Return on equity info -71.73-42.40---96.74-69.98
Return on Capital info -59.62-31.26---67.60-64.50
Return on Assets info -46.49-23.68-42.54-51.01-48.05
Debt to Equity (x) info ------0.850.10

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
-67.60
-64.50
-46.76
65.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
-96.74
-69.98
-48.46
70.68
Peer Median
-26.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-42.54

Lower than Peers by 29.57

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
-42.54
-51.01
-48.05
-40.40
59.10
Peer Median
-12.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-549.20

Lower than Peers by 489.50

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
-549.20
-349.61
-236.83
-1,387.44
1,685.59
Peer Median
-59.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-400.00

Lower than Peers by 328.94

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
-400.00
-348.01
-239.65
-1,382.77
1,530.62
Peer Median
-71.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-30.37

Lower than Peers by 50.92

Year on year growth in net sales

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
-30.37
-0.17
7.55
0.09
-0.73
Peer Median
20.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

16.03

Higher than Peers by 0.83

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
16.03
-22.24
-45.91
-189.59
347.29
Peer Median
15.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

38.86

Higher than Peers by 30.99

Year on year growth in profit after tax

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
38.86
-20.24
-48.15
-198.32
313.49
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

--

--

Year on year growth in earnings per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
-0.06
-0.33
-1.90
2.93
Peer Median
30.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
0.85
0.10
0.07
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
0.02
0.01
0.01
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.83

Higher than Peers by 0.34

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
3.83
5.15
2.16
7.31
10.38
Peer Median
3.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

3.82

Higher than Peers by 0.53

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
3.82
4.80
2.08
7.31
10.38
Peer Median
3.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-26.58

Lower than Peers by 25.07

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
-26.58
-250.02
-289.04
-178.93
42.45
Peer Median
-1.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

47.14

Higher than Peers by 22.81

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
47.14
37.73
3.59
38.19
20.64
Peer Median
24.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.11

Lower than Peers by 0.12

Sales / Average Total Assets

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
0.11
0.15
0.20
0.03
0.04
Peer Median
0.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
76.83
14.72
104.38
192.10
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
252.29
92.15
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
190.39
235.61
39,686.83
62.90
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Zealand Pharma A/S - ADR
--
138.73
-128.73
-39,582.45
129.20
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...